NIOX Group Plc (CSSPF)
USD 0.65
(-13.33%)
USD 0.65
(-13.33%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.4 Million USD | 15.78% |
| 2022 | 1.2 Million USD | -31.18% |
| 2021 | 1.75 Million USD | -19.65% |
| 2020 | 2.18 Million USD | -98.53% |
| 2019 | 148.37 Million USD | 0.0% |
| 2018 | - GBP | 0.0% |
| 2017 | - GBP | 0.0% |
| 2016 | - GBP | 0.0% |
| 2015 | - GBP | 0.0% |
| 2014 | - GBP | -100.0% |
| 2013 | 2.01 Million GBP | 0.5% |
| 2012 | 2 Million GBP | 0.6% |
| 2011 | 1.99 Million GBP | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 758.58 Thousand USD | 200.0% |
| 2023 FY | 1.4 Million USD | 15.78% |
| 2023 Q4 | 1.4 Million USD | 129.55% |
| 2023 Q3 | 610 Thousand GBP | -65.67% |
| 2023 Q2 | 1.77 Million USD | 80.05% |
| 2023 Q1 | 986.93 Thousand GBP | -18.39% |
| 2022 Q3 | 446.68 Thousand GBP | -75.53% |
| 2022 Q4 | 1.2 Million USD | 170.75% |
| 2022 FY | 1.2 Million USD | -31.18% |
| 2022 Q1 | 1.18 Million GBP | -32.72% |
| 2022 Q2 | 1.82 Million GBP | 54.42% |
| 2021 Q3 | 1.21 Million GBP | -48.36% |
| 2021 Q1 | 1.51 Million GBP | -30.67% |
| 2021 Q2 | 2.34 Million GBP | 54.88% |
| 2021 Q4 | 1.75 Million GBP | 44.9% |
| 2021 FY | 1.75 Million USD | -19.65% |
| 2020 Q2 | 2.34 Million GBP | 45.25% |
| 2020 FY | 2.18 Million USD | -98.53% |
| 2020 Q4 | 2.18 Million GBP | 111.88% |
| 2020 Q3 | 1.03 Million GBP | -56.03% |
| 2020 Q1 | 1.61 Million GBP | -98.91% |
| 2019 Q3 | 136.97 Million GBP | 382.64% |
| 2019 Q4 | 148.37 Million GBP | 8.32% |
| 2019 Q2 | 28.38 Million GBP | 1.36% |
| 2019 Q1 | 28 Million GBP | 0.0% |
| 2019 FY | 148.37 Million USD | 0.0% |
| 2018 Q1 | - GBP | 0.0% |
| 2018 FY | - GBP | 0.0% |
| 2018 Q4 | - GBP | 0.0% |
| 2018 Q3 | - GBP | 0.0% |
| 2018 Q2 | - GBP | 0.0% |
| 2017 Q2 | - GBP | 0.0% |
| 2017 Q1 | - GBP | 0.0% |
| 2017 FY | - GBP | 0.0% |
| 2017 Q4 | - GBP | 0.0% |
| 2017 Q3 | - GBP | 0.0% |
| 2016 Q4 | - GBP | 0.0% |
| 2016 Q1 | - GBP | 0.0% |
| 2016 FY | - GBP | 0.0% |
| 2016 Q3 | - GBP | 0.0% |
| 2016 Q2 | - GBP | 0.0% |
| 2015 Q1 | - GBP | 0.0% |
| 2015 FY | - GBP | 0.0% |
| 2015 Q4 | - GBP | 0.0% |
| 2015 Q3 | - GBP | 0.0% |
| 2015 Q2 | - GBP | 0.0% |
| 2014 Q4 | - GBP | 0.0% |
| 2014 Q1 | - GBP | -100.0% |
| 2014 Q2 | - GBP | 0.0% |
| 2014 Q3 | - GBP | 0.0% |
| 2014 FY | - GBP | -100.0% |
| 2013 Q3 | 3.25 Million GBP | 0.0% |
| 2013 Q4 | 2.01 Million GBP | -38.23% |
| 2013 Q1 | - GBP | 0.0% |
| 2013 FY | 2.01 Million GBP | 0.5% |
| 2012 FY | 2 Million GBP | 0.6% |
| 2011 FY | 1.99 Million GBP | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| BioElectronics Corporation | 14.83 Million USD | 90.558% |
| Medical Supply International USA, Inc. | 227 Thousand USD | -516.867% |
| Polarean Imaging plc | 216.38 Thousand USD | -547.134% |
| Avitar, Inc. | 5.26 Million USD | 73.405% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | 161 Thousand USD | -769.752% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -211.536% |
| Manhattan Scientifics, Inc. | 60 Thousand USD | -2233.833% |
| Össur hf. | 467.73 Million USD | 99.701% |
| Zecotek Photonics Inc. | 3.22 Million USD | 56.538% |
| QHSLab, Inc. | 1.78 Million USD | 21.4% |
| Wellstar International, Inc. | 51.36 Million USD | 97.274% |
| Össur hf. | 467.73 Million USD | 99.701% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 5.21 Million USD | 73.164% |
| Escalon Medical Corp. | 524.71 Thousand USD | -166.867% |
| Aurora Spine Corporation | 2.67 Million USD | 47.565% |
| BrainsWay Ltd. | 471 Thousand USD | -197.304% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 3 Million USD | 53.323% |
| Hamilton Thorne Ltd. | 27.81 Million USD | 94.965% |
| Vivos Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 1.69 Billion USD | 99.918% |
| Kelyniam Global, Inc. | 496.39 Thousand USD | -182.092% |
| REMSleep Holdings, Inc. | 178.11 Thousand USD | -686.182% |
| CYduct Diagnostics, Inc. | 670 Thousand USD | -109.0% |
| Nanomix Corporation | 11.4 Million USD | 87.723% |
| Theraclion SA | 1.95 Million EUR | 28.217% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 4.04 Million USD | 65.356% |
| Positron Corporation | 1.78 Million USD | 21.663% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.69 Million USD | 17.559% |
| Lombard Medical, Inc. | 32.29 Million USD | 95.664% |
| ALR Technologies Inc. | 19.26 Million USD | 92.731% |
| Stratec SE | 156.16 Million USD | 99.103% |
| Vycor Medical, Inc. | 1.11 Million USD | -26.125% |
| Heart Tronics, Inc. | 209.28 Thousand USD | -569.088% |
| Nu-Med Plus, Inc. | 100 Thousand USD | -1300.3% |
| Perimeter Medical Imaging AI, Inc. | 192.89 Thousand USD | -625.943% |
| SANUWAVE Health, Inc. | 31.94 Million USD | 95.616% |
| VMS Rehab Systems, Inc. | 133.52 USD | -1048656.741% |
| Guided Therapeutics, Inc. | 2.05 Million USD | 31.958% |
| Ingen Technologies, Inc. | 631.15 Thousand USD | -121.862% |
| Odyssey Group International, Inc. | 2.14 Million USD | 34.708% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | 3.17 Million USD | 55.844% |
| Capital Group Holdings, Inc. | 4944.00 USD | -28223.22% |
| ADM Tronics Unlimited, Inc. | 799.65 Thousand USD | -75.112% |
| Urologix, Inc. | 5.33 Million USD | 73.743% |
| Rapid Therapeutic Science Laboratories, Inc. | 3.83 Million USD | 63.445% |
| Nexeon MedSystems Inc. | 4.21 Million USD | 66.78% |
| SS Innovations International, Inc. | 8.21 Million USD | 82.961% |
| Qualis Innovations, Inc. | 9102.00 USD | -15284.531% |
| Smith & Nephew plc | 3.07 Billion USD | 99.955% |
| Fuse Medical, Inc. | 1.99 Million USD | 29.762% |
| Broncus Holding Corporation | 2.35 Million USD | 40.523% |
| Brain Scientific Inc. | 2.86 Million USD | 51.098% |
| Pressure BioSciences, Inc. | 22.75 Million USD | 93.847% |
| Health Logic Interactive Inc. | 40.44 Thousand USD | -3362.489% |